Innospec Q3 EPS $0.52 GAAP ($1.12 adj), down from $1.33; impairments of $42.9M; dividend +10%

INNOSPEC INC.

2025-Q3 EPS reported $2.76 vs consensus $1.08 ▲ beat (+155.3%)

Revenue $441.9M flat YoY; net income $12.9M vs $33.4M; adjusted EBITDA $44.2M vs $50.5M.
GAAP EPS $0.52; adjusted non-GAAP EPS $1.12, down from $1.35; special items net $24.4M charge.
Impairments and restructuring of $42.9M in oilfield production and US stimulation businesses, offset by $18.5M contingent consideration reduction.
Semi-annual dividend raised 10% to $0.87/share ($1.71 annual), payable Nov 26 to holders of record Nov 18.
Operating cash flow $39.3M; net cash $270.8M; $10.7M share repurchases in quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.